Linji Gong
Papers
1
Total Citations
35
H-Index
1
About
Dr. Linji Gong is a pioneering researcher at the forefront of nanomedicine and biomedical engineering, with a specialized focus on liquid metal nanoparticles for cancer therapy. His most notable contribution involves the first-ever utilization of nanosized gallium-indium liquid metal particles as transformable agents for tumor radiotherapy sensitization, a breakthrough published in 2022 that has already garnered 35 citations. This innovative work demonstrates how these unique, room-temperature liquid metal nanoparticles can be engineered to enhance the efficacy of radiation treatment, offering a novel strategy to overcome radioresistance in solid tumors. Dr. Gong’s research bridges materials science and clinical oncology, showcasing the transformative potential of gallium-based liquid metals beyond traditional applications in microfluidics and soft robotics. By pioneering the biomedical application of these materials at the nanoscale, he has opened new avenues for targeted, multimodal cancer therapies. His work is recognized for its high impact and translational promise, positioning him as an emerging leader in the development of next-generation nanotherapeutics for precision oncology.
Research Focus
Key Achievements
Top Papers
- 1